Verified 2026-2035 Industry Projections
support@absolutemarketresearch.com
Back to All Analysts
D
Verified Senior Practice Lead

Dr. Elena Rostova

Senior Biotech & Pharmaceutical Lead Analyst
Ph.D. Molecular Biology, M.Sc. BiochemistryPh.D. Molecular Biology (Johns Hopkins University), M.Sc. Biochemistry

Analyst Biography & Expertise

Dr. Elena Rostova brings 12 years of clinical research and pharmaceutical market analysis experience. Holding a Ph.D. in Molecular Biology, she leads the Healthcare & Biotechnology vertical at Absolute Market Research. Her research focuses on Generative AI transformer neural networks in drug design, oncology target discovery, GLP-1 weight-loss therapeutics, and rare disease commercial valuation across North America and Europe.

Core Industry Specializations

Oncology TherapeuticsGenerative AI Drug DiscoveryBiopharma Pipeline SizingClinical Trial Analytics

Published Executive Insights (3)

Healthcare & BiotechSeptember 15, 2026
Generative AI in Oncology Drug Discovery: 2026-2035 Clinical Revenue Forecast

An examination of how transformer neural networks are reducing preclinical drug lead identification times from 4 years to 8 months, reshaping biopharma valuation models.

SemiconductorsSeptember 01, 2026
Next-Generation Semiconductor EUV Lithography Market: 1.4nm Node Scaling Roadmap

Analyzing High-NA EUV optics adoption, anamorphic magnification, and foundry capital expenditure requirements for sub-2nm silicon fabrication.

PharmaceuticalsAugust 25, 2026
GLP-1 Weight Loss & Anti-Obesity Therapeutics: Commercial Sizing & Pipeline Analysis

Modeling oral vs injectable peptide market share, cardiovascular outcome trials, and supply chain capacity expansion across North America and Europe.

Research Stats

Syndicated Studies3,100+
Published Articles38
Academic BackgroundPh.D. Molecular Biology (Johns Hopkins University), M.Sc. Biochemistry
Primary OfficeNew York, NY

Featured Practice Reports

Home
Sectors
Insights
Authors
Methodology
Analysis
Sitemap
Privacy
Disclaimer
Contact